BioSpace News Archive

Business

Science 37 Reports First Quarter 2023 Financial Results

Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended March 31, 2023.

May 15, 2023
·
15 min read
Biotech Bay

Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma

Hummingbird Bioscience announced it has entered into a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001 in combination with cetuximab in squamous non-small cell lung carcinoma.

May 15, 2023
·
3 min read
Biotech Bay

ASLAN Pharmaceuticals Presents New Data on Eblasakimab and Farudodstat in Two Late-Breaking Presentations at the 1st International Societies for Investigative Dermatology Meeting

ASLAN Pharmaceuticals today announced the presentation of new eblasakimab and farudodstat data in late-breaker oral and poster presentations respectively, at the 1st International Societies for Investigative Dermatology (ISID) meeting, which took place from May 10 to 13, 2023, in Tokyo, Japan.

May 15, 2023
·
10 min read
Business

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Nusano, Inc. and PharmaLogic today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.

May 15, 2023
·
3 min read
Business

Compugen Reports First Quarter 2023 Results

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key events since the start of 2023.

May 15, 2023
·
9 min read
Business

Leap Therapeutics Reports First Quarter 2023 Financial Results

Leap Therapeutics, Inc. today reported financial results for first quarter ended March 31, 2023.

May 15, 2023
·
11 min read
Business

BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

BrainStorm Cell Therapeutics Inc. today announced financial results for the quarter ended March 31, 2023 and provided a corporate update.

May 15, 2023
·
10 min read
Business

Potrero Medical Announces Maclean Health as Government Sector Distributor of Record

Potrero Medical, innovator of the Accuryn Monitoring System, announced today that it has signed Maclean Health as its Exclusive Distributor of Record for Federal Government Healthcare facilities to include the 171 Veteran Affairs (VA) Hospitals in the US.

May 15, 2023
·
2 min read
Drug Development

Newron Presents Exciting New Data From Study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

Study 014/015 is a Phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia (TRS).

May 15, 2023
·
10 min read
BioMidwest

POINT Biopharma Makes Strategic Investment in Commercial-Scale Alpha-Emitting Isotope ManufacturerPOINT further strengthens supply chain with $10 million investment in Ionetix Alpha Corp.

POINT Biopharma Global Inc. and IONETIX Corporation announced a collaboration to create Ionetix Alpha Corp.

May 15, 2023
·
6 min read